WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'0101 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 11'3881 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 16'144  15'903  15'661  15'419  15'177  12'629  10'218  7'976 
Births 331  331  330  329  328  314  308  277 
Surviving infants 324  324  323  322  321  305  293  257 
Pop. less than 5 years 1'610  1'608  1'607  1'604  1'594  1'519  1'417  1'224 
Pop. less than 15 years 4'685  4'666  4'649  4'634  4'615  4'387  3'905  3'339 
Female 15-49 years 4'228  4'170  4'109  4'044  3'980  3'263  2'537  1'853 

Number of reported cases

(Click for retrospective incidence data for Ecuador)
Diphtheria
ChartChart
  16 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  72  257  1'646  2'722 
Mumps
ChartChart
  1'491  1'522  1'308  799  733 
Pertussis
ChartChart
  35  54  482  487  836 
Polio*
ChartChart
  11 
Rubella
ChartChart
  538 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  88  28 
Tetanus (total)**
ChartChart
  49  27  28  169  81 
Yellow fever
ChartChart
  12 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ecuador)
Vaccine year result method % card seen                                                
BCG 2011  98     88  88  89  90  99*  99*  99*  99  75 
DTP1          80  84  87  99*  99*  99* 
DTP3 2011  88     88  78  83  87  99*  99*  88  75  10 
DTP4          59  70 
IPV1          72 
HepB_BD          75  79  69  16  40 
HepB3          78  83  87  99*  99*  40 
Hib3          78  83  87  99*  99* 
JapEnc         
MCV1          84  85  97  99*  94  84  67  24 
MCV2          76  59  83  55  92 
PCV1          81  83  86  99*  99* 
PCV3          81  99*  90  94  71 
Pol3 2011  85     88  84  84  87  99*  99*  84  77  19 
Rota1          81  84  85  99*  99* 
RotaC          78  81  83  99*  99* 
RCV1          84  70  97  99*  94 
TT2plus 1988  48  MCH     76  54  64  75  75  31 
PAB         
VAD1          84 
YFV          78  86  73  89  89  28 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ecuador)
BCG
ChartChart
  88  89  90  94  98  99  89  76 
DTP1
ChartChart
  80  84  87  88  89  94  87  31 
DTP3
ChartChart
  78  83  87  87  88  87  68  10 
HepB3
ChartChart
  78  83  87  88  88  36 
HepB_BD
ChartChart
  75  79  69  16 
Hib3
ChartChart
  78  83  87  87  88 
IPV1
ChartChart
 
MCV1
ChartChart
  84  85  97  96  94  99  60  24 
MCV2
ChartChart
  76  59  70  81  92 
PAB
ChartChart
  88  85  85  85  85  42  82 
PCV3
ChartChart
  81  86  90  94  71 
Pol3
ChartChart
  84  84  87  85  85  83  67  19 
RCV1
ChartChart
  84  85  97  96  94  99 
RotaC
ChartChart
  78  81  83  87  90 
YFV
ChartChart
  78  86  73  74  74 

Number of districts in the country 222  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 16
From 80 to 89% 27
From 50 to 79% 51
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9 years (x2); Yes
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes
IPV 2 months Yes
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, pregnant women, health care workers
Influenza_Pediatric 6 months to 4 years; Yes and children with chronic diseases
MMR 12, 18 months; Yes
MR < 7 years; Yes with no vaccination history or in case of outbreaks
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; Yes
Td 15 years; Yes according to vaccination history, completing the schedule of 5 doses
Varicella 15 months; Yes
YF 12-23 months; Yes and travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2010-2016  2010-2016  2'015  2011 -2016  2011-2015  4 years   
Nº of districts with microplans that include activities to raise immunization coverage number 140    76  24  80  24 

System performance

Total Nº districts in country number 222  221  223  220  171  170  210 
Nº districts with DTP3 coverage >=80% number 95  115  151    142  146  151 
% of districts with DTP3 coverage >=80% From 0 to 100% 43  52  68    83  86  72 
Nº districts with measles (MCV1) coverage >=95% number 33  47  95  NA  66  112  116 
% of districts with MCV1 coverage >=95% From 0 to 100% 15  21  43    39  66  55 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100    100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.